Home » Topics » BioWorld Science

BioWorld Science
RSS

Vallon Pharmaceuitcals presents results on manipulated dextroamphetamine sulfate

Jan. 28, 2020

Retinoic X receptor as therapeutic target for poststroke recovery

Jan. 28, 2020

Targeting SK1 overcomes resistance to immune checkpoint inhibitors in melanoma

Jan. 28, 2020

LNA-anti-miR-150 ameliorates FSGS in vivo

Jan. 28, 2020

Otsuka reports promising topline data from Japanese trials of fremanezumab in migraine

Jan. 28, 2020

FDA clears NeoImmuneTech's IND to study NT-I7 plus pembrolizumab in advanced solid tumors

Jan. 28, 2020

FDA approves Dificid for C. difficile infection in children age 6 months and older

Jan. 28, 2020

Genetic removal of mast cell Tph1 protects mice from developing obesity and insulin resistance

Jan. 28, 2020

New phase III trial evaluates MK-6482 in advanced renal cell carcinoma

Jan. 28, 2020

Glial cells contribute to brain control of aging

Jan. 28, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 5, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
Axsome’s Auvelity cleared for large Alzheimer’s agitation market
BioWorld
Axsome Therapeutics Inc. won U.S. FDA approval for Auvelity (AXS-05) to treat Alzheimer’s disease agitation, a condition that affects up to three-quarters of...
Sonire starts US study of cancer HIFU after $18M series A
BioWorld
Sonire Therapeutics Inc. initiated a U.S.-based Sunrise II study of Suizenji, its novel ultrasound-guided high-intensity focused ultrasound (HIFU) system designed...
Other news to note for May 1, 2026
BioWorld
Biopharma and med-tech happenings, including deals and partnerships, and other news in brief: AC Immune, Aptose, Astrazeneca, Bioreference Health, Cardioline,...